GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Jiangsu Sinopep Allsino Biopharmaceutical Co 688076.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

27.90

+1.31%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

8 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 4Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 51.15

Low
50.64
Average
51.15
Median
51.15
High
52.65

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027
RevenueCN¥2.35bnCN¥2.67bn
Revenue, highestCN¥2.35bnCN¥2.67bn
Revenue, lowestCN¥2.35bnCN¥2.67bn
Earnings per share2.212.79
Earnings per share, highest2.212.79
Earnings per share, lowest2.212.79
Analysts11

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024
Forecast0.100.210.290.200.100.21
Reported0.500.220.240.560.700.31
Difference+400.0%+6.9%-16.8%+180.0%+599.0%+50.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 71.6% a year over 10 years. Return on equity 11.0%.

Model fair value

54.78

From earnings 54.78, from revenue 44.07.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.